1. Home
  2. MAN vs MNKD Comparison

MAN vs MNKD Comparison

Compare MAN & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ManpowerGroup

MAN

ManpowerGroup

HOLD

Current Price

$33.72

Market Cap

1.4B

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$4.24

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAN
MNKD
Founded
1948
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
MAN
MNKD
Price
$33.72
$4.24
Analyst Decision
Hold
Buy
Analyst Count
6
8
Target Price
$35.67
$8.69
AVG Volume (30 Days)
1.1M
4.8M
Earning Date
04-16-2026
05-06-2026
Dividend Yield
4.69%
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$17,957,100,000.00
$348,966,000.00
Revenue This Year
$5.12
$35.81
Revenue Next Year
$3.42
$11.89
P/E Ratio
$675.40
N/A
Revenue Growth
0.58
22.23
52 Week Low
$25.15
$2.23
52 Week High
$47.34
$6.51

Technical Indicators

Market Signals
Indicator
MAN
MNKD
Relative Strength Index (RSI) 53.65 69.60
Support Level $28.29 $2.56
Resistance Level $36.87 $4.29
Average True Range (ATR) 1.64 0.21
MACD 0.04 0.03
Stochastic Oscillator 38.49 88.20

Price Performance

Historical Comparison
MAN
MNKD

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: